Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Beverly M.K. Biller, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. F32DK008330 (BILLER, BEVERLY M) Sep 1, 1989
    NIH/NIDDK
    PATHOGENESIS AND REGULATION OF CORTICOTROPH ADENOMAS
    Role: Principal Investigator
  2. M01RR001066 (SLAVIN, PETER L) Feb 1, 1978 - May 31, 2008
    NIH/NCRR
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Buchfelder M, van der Lely AJ, Biller BMK, Webb SM, Brue T, Strasburger CJ, Ghigo E, Camacho-Hubner C, Pan K, Lavenberg J, Jönsson P, Hey-Hadavi JH. Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY. Eur J Endocrinol. 2018 Dec 01; 179(6):419-427. PMID: 30325178.
    Citations:    Fields:    Translation:Humans
  2. Yuen KCJ, Miller BS, Biller BMK. The current state of long-acting growth hormone preparations for growth hormone therapy. Curr Opin Endocrinol Diabetes Obes. 2018 08; 25(4):267-273. PMID: 29746309.
    Citations:    Fields:    
  3. Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, Chanson P, Medic-Stojanoska M, Schopohl J, Zakrzewska A, Pekic S, Bolanowski M, Swerdloff R, Wang C, Blevins T, Marcelli M, Ammer N, Sachse R, Yuen KCJ. Macimorelin as a Diagnostic Test for Adult GH Deficiency. J Clin Endocrinol Metab. 2018 08 01; 103(8):3083-3093. PMID: 29860473.
    Citations:    Fields:    
  4. Jahandideh D, Swearingen B, Nachtigall LB, Klibanski A, Biller BMK, Tritos NA. Characterization of cyclic Cushing's disease using late night salivary cortisol testing. Clin Endocrinol (Oxf). 2018 Sep; 89(3):336-345. PMID: 29873834.
    Citations:    Fields:    
  5. Tritos NA, Biller BMK. Medical Therapy for Cushing's Syndrome in the Twenty-first Century. Endocrinol Metab Clin North Am. 2018 06; 47(2):427-440. PMID: 29754642.
    Citations:    Fields:    Translation:Humans
  6. Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P, Clayton PE, Choong CS, Clemmons D, Dattani M, Frystyk J, Ho K, Hoffman AR, Horikawa R, Juul A, Kopchick JJ, Luo X, Neggers S, Netchine I, Olsson DS, Radovick S, Rosenfeld R, Ross RJ, Schilbach K, Solberg P, Strasburger C, Trainer P, Yuen KCJ, Wickstrom K, Jorgensen JOL. Growth Hormone Research Society perspective on biomarkers of GH action in children and adults. Endocr Connect. 2018 Mar; 7(3):R126-R134. PMID: 29483159.
    Citations:    
  7. Strasburger CJ, Mattsson A, Wilton P, Aydin F, Hey-Hadavi J, Biller BMK. Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant. Eur J Endocrinol. 2018 Apr; 178(4):321-329. PMID: 29371335.
    Citations:    Fields:    Translation:Humans
  8. Fahlbusch R, Kleinberg D, Biller B, Bonert V, Buchfelder M, Cappabianca P, Carmichael J, Chandler W, Colao A, George A, Klibanski A, Knopp E, Kreutzer J, Kundurti N, Lesser M, Mamelak A, Pivonello R, Post K, Swearingen B, Vance ML, Barkan A. Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary. 2017 Dec; 20(6):668-675. PMID: 28825168.
    Citations: 2     Fields:    Translation:Humans
  9. Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J. Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. Lancet Diabetes Endocrinol. 2018 01; 6(1):17-26. PMID: 29032078.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  10. Silva PPB, Amlashi FG, Yu EW, Pulaski-Liebert KJ, Gerweck AV, Fazeli PK, Lawson E, Nachtigall LB, Biller BMK, Miller KK, Klibanski A, Bouxsein M, Tritos NA. Bone microarchitecture and estimated bone strength in men with active acromegaly. Eur J Endocrinol. 2017 Nov; 177(5):409-420. PMID: 28780520.
    Citations:    Fields:    Translation:Humans
  11. Geer EB, Ayala A, Bonert V, Carmichael JD, Gordon MB, Katznelson L, Manuylova E, Shafiq I, Surampudi V, Swerdloff RS, Broder MS, Cherepanov D, Eagan M, Lee J, Said Q, Neary MP, Biller BMK. Follow-up intervals in patients with Cushing's disease: recommendations from a panel of experienced pituitary clinicians. Pituitary. 2017 Aug; 20(4):422-429. PMID: 28275992.
    Citations:    Fields:    Translation:Humans
  12. Geer EB, Shafiq I, Gordon MB, Bonert V, Ayala A, Swerdloff RS, Katznelson L, Lalazar Y, Manuylova E, Pulaski-Liebert KJ, Carmichael JD, Hannoush Z, Surampudi V, Broder MS, Cherepanov D, Eagan M, Lee J, Said Q, Neary MP, Biller BMK. BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY. Endocr Pract. 2017 Aug; 23(8):962-970. PMID: 28614003.
    Citations: 1     Fields:    Translation:Humans
  13. Petersenn S, Salgado LR, Schopohl J, Portocarrero-Ortiz L, Arnaldi G, Lacroix A, Scaroni C, Ravichandran S, Kandra A, Biller BMK. Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial. Endocrine. 2017 Jul; 57(1):156-165. PMID: 28597198.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  14. Höybye C, Weber MM, Pournara E, Tønnes Pedersen B, Biller BMK. Is GH dosing optimal in female patients with adult-onset GH deficiency? An analysis from the NordiNet® International Outcome Study. Clin Endocrinol (Oxf). 2017 Jun; 86(6):798-805. PMID: 28306165.
    Citations:    Fields:    Translation:Humans
  15. Gunnarsson C, Ryan MP, Marelli C, Baker ER, Stewart PM, Johannsson G, Biller BMK. Health Care Burden in Patients With Adrenal Insufficiency. J Endocr Soc. 2017 May 01; 1(5):512-523. PMID: 29264506.
    Citations:    
  16. Burman P, van Beek AP, Biller BM, Camacho-Hübner C, Mattsson AF. Radiotherapy, Especially at Young Age, Increases the Risk for De Novo Brain Tumors in Patients Treated for Pituitary/Sellar Lesions. J Clin Endocrinol Metab. 2017 Mar 01; 102(3):1051-1058. PMID: 28359095.
    Citations: 5     Fields:    
  17. Tritos NA, Biller BM. Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly. Pituitary. 2017 Feb; 20(1):129-135. PMID: 27631335.
    Citations:    Fields:    Translation:Humans
  18. Strasburger CJ, Vanuga P, Payer J, Pfeifer M, Popovic V, Bajnok L, Góth M, Olšovská V, Trejbalová L, Vadasz J, Fima E, Koren R, Amitzi L, Bidlingmaier M, Hershkovitz O, Hart G, Biller BMK. MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults. Eur J Endocrinol. 2017 Mar; 176(3):283-294. PMID: 27932411.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  19. Weber MM, Biller BM, Pedersen BT, Pournara E, Christiansen JS, Höybye C. The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet® International Outcome Study. Clin Endocrinol (Oxf). 2017 Feb; 86(2):192-198. PMID: 27736009.
    Citations: 1     Fields:    Translation:Humans
  20. Tritos NA, Chanson P, Jimenez C, King D, Jönsson PJ, Klibanski A, Biller BM. Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. Eur J Endocrinol. 2017 Feb; 176(2):213-220. PMID: 27932529.
    Citations: 1     Fields:    Translation:Humans
  21. Stewart PM, Biller BM, Marelli C, Gunnarsson C, Ryan MP, Johannsson G. Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency. J Clin Endocrinol Metab. 2016 12; 101(12):4843-4850. PMID: 27623069.
    Citations: 1     Fields:    Translation:Humans
  22. Faje A, Chunharojrith P, Nency J, Biller BM, Swearingen B, Klibanski A. Dopamine Agonists Can Reduce Cystic Prolactinomas. J Clin Endocrinol Metab. 2016 10; 101(10):3709-3715. PMID: 27459530.
    Citations: 3     Fields:    Translation:Humans
  23. Hamrahian AH, Yuen KC, Gordon MB, Pulaski-Liebert KJ, Bena J, Biller BM. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. Pituitary. 2016 Jun; 19(3):332-41. PMID: 26897383.
    Citations: 5     Fields:    Translation:Humans
  24. Findling JW, Fleseriu M, Newell-Price J, Petersenn S, Pivonello R, Kandra A, Pedroncelli AM, Biller BM. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study. Endocrine. 2016 Nov; 54(2):516-523. PMID: 27209465.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  25. Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol. 2016 07; 4(7):611-29. PMID: 27177728.
    Citations: 7     Fields:    Translation:Humans
  26. Fleseriu M, Pivonello R, Young J, Hamrahian AH, Molitch ME, Shimizu C, Tanaka T, Shimatsu A, White T, Hilliard A, Tian C, Sauter N, Biller BM, Bertagna X. Osilodrostat, a potent oral 11ß-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease. Pituitary. 2016 Apr; 19(2):138-48. PMID: 26542280.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  27. Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, Chanson P, Chatelain P, Choong CS, Clemmons DR, Cohen LE, Cohen P, Frystyk J, Grimberg A, Hasegawa Y, Haymond MW, Ho K, Hoffman AR, Holly JM, Horikawa R, Höybye C, Jorgensen JO, Johannsson G, Juul A, Katznelson L, Kopchick JJ, Lee KO, Lee KW, Luo X, Melmed S, Miller BS, Misra M, Popovic V, Rosenfeld RG, Ross J, Ross RJ, Saenger P, Strasburger CJ, Thorner MO, Werner H, Yuen K. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations. Eur J Endocrinol. 2016 Jun; 174(6):C1-8. PMID: 27009113.
    Citations: 6     Fields:    Translation:Humans
  28. Javorsky BR, Carroll TB, Tritos NA, Salvatori R, Heaney AP, Fleseriu M, Biller BM, Findling JW. Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients. Obes Surg. 2015 Dec; 25(12):2306-13. PMID: 25917980.
    Citations:    Fields:    Translation:Humans
  29. Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Sorensen HT, Stochholm K, Strasburger C, Swerdlow A, Thorner M. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 2016 02; 174(2):P1-9. PMID: 26563978.
    Citations: 22     Fields:    Translation:Humans
  30. Papoian V, Biller BM, Webb SM, Campbell KK, Hodin RA, Phitayakorn R. PATIENTS' PERCEPTION ON CLINICAL OUTCOME AND QUALITY OF LIFE AFTER A DIAGNOSIS OF CUSHING SYNDROME. Endocr Pract. 2016 Jan; 22(1):51-67. PMID: 26437213.
    Citations: 2     Fields:    Translation:Humans
  31. Vila G, Akerblad AC, Mattsson AF, Riedl M, Webb SM, Hána V, Nielsen EH, Biller BM, Luger A. Pregnancy outcomes in women with growth hormone deficiency. Fertil Steril. 2015 Nov; 104(5):1210-7.e1. PMID: 26256649.
    Citations: 2     Fields:    Translation:Humans
  32. Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015 Aug; 100(8):2807-31. PMID: 26222757.
    Citations: 71     Fields:    Translation:Humans
  33. Amlashi FG, Swearingen B, Faje AT, Nachtigall LB, Miller KK, Klibanski A, Biller BM, Tritos NA. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. J Clin Endocrinol Metab. 2015 Oct; 100(10):3770-7. PMID: 26196950.
    Citations: 6     Fields:    Translation:Humans
  34. Høybye C, Cohen P, Hoffman AR, Ross R, Biller BM, Christiansen JS. Status of long-acting-growth hormone preparations--2015. Growth Horm IGF Res. 2015 Oct; 25(5):201-6. PMID: 26187188.
    Citations: 10     Fields:    Translation:Humans
  35. Tritos NA, Biller BM. Update on radiation therapy in patients with Cushing's disease. Pituitary. 2015 Apr; 18(2):263-8. PMID: 25359445.
    Citations: 3     Fields:    Translation:Humans
  36. Dichtel LE, Yuen KC, Bredella MA, Gerweck AV, Russell BM, Riccio AD, Gurel MH, Sluss PM, Biller BM, Miller KK. Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency. J Clin Endocrinol Metab. 2014 Dec; 99(12):4712-9. PMID: 25210883.
    Citations: 12     Fields:    Translation:Humans
  37. Wattson DA, Tanguturi SK, Spiegel DY, Niemierko A, Biller BM, Nachtigall LB, Bussière MR, Swearingen B, Chapman PH, Loeffler JS, Shih HA. Outcomes of proton therapy for patients with functional pituitary adenomas. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):532-9. PMID: 25194666.
    Citations: 9     Fields:    Translation:Humans
  38. Boscaro M, Bertherat J, Findling J, Fleseriu M, Atkinson AB, Petersenn S, Schopohl J, Snyder P, Hughes G, Trovato A, Hu K, Maldonado M, Biller BM. Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study. Pituitary. 2014 Aug; 17(4):320-6. PMID: 23943009.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  39. Lazure P, Bartel RC, Biller BM, Molitch ME, Rosenthal SM, Ross JL, Bernsten BD, Hayes SM. Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology. BMC Health Serv Res. 2014 Jul 24; 14:319. PMID: 25060235.
    Citations: 1     Fields:    Translation:Humans
  40. Jho DH, Biller BM, Agarwalla PK, Swearingen B. Pituitary apoplexy: large surgical series with grading system. World Neurosurg. 2014 Nov; 82(5):781-90. PMID: 24915069.
    Citations: 9     Fields:    Translation:Humans
  41. Tritos NA, Johannsson G, Korbonits M, Miller KK, Feldt-Rasmussen U, Yuen KC, King D, Mattsson AF, Jonsson PJ, Koltowska-Haggstrom M, Klibanski A, Biller BM. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. J Clin Endocrinol Metab. 2014 Jun; 99(6):2018-29. PMID: 24694339.
    Citations: 4     Fields:    Translation:Humans
  42. Barake M, Evins AE, Stoeckel L, Pachas GN, Nachtigall LB, Miller KK, Biller BM, Tritos NA, Klibanski A. Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary. 2014 Apr; 17(2):150-6. PMID: 23504371.
    Citations: 6     Fields:    Translation:Humans
  43. Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM. Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. Clin Endocrinol (Oxf). 2014 Sep; 81(3):408-17. PMID: 24533697.
    Citations: 25     Fields:    Translation:HumansCTClinical Trials
  44. Tritos NA, Biller BM. Cushing's disease. Handb Clin Neurol. 2014; 124:221-34. PMID: 25248590.
    Citations: 6     Fields:    Translation:HumansAnimals
  45. Bertagna X, Pivonello R, Fleseriu M, Zhang Y, Robinson P, Taylor A, Watson CE, Maldonado M, Hamrahian AH, Boscaro M, Biller BM. LCI699, a potent 11ß-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study. J Clin Endocrinol Metab. 2014 Apr; 99(4):1375-83. PMID: 24423285.
    Citations: 32     Fields:    Translation:HumansCTClinical Trials
  46. Tritos NA, Biller BM. Medical management of Cushing's disease. J Neurooncol. 2014 May; 117(3):407-14. PMID: 24146187.
    Citations: 6     Fields:    Translation:Humans
  47. Tritos NA, Eppakayala S, Swearingen B, Hedley-Whyte ET, Miller KK, Nachtigall LB, Grinspoon SK, Biller BM, Klibanski A. Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity. Pituitary. 2013 Sep; 16(3):287-93. PMID: 22869255.
    Citations: 4     Fields:    Translation:Humans
  48. Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ. 12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency. Pituitary. 2013 Sep; 16(3):311-8. PMID: 22915288.
    Citations: 4     Fields:    Translation:Humans
  49. Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Sen K, Salgado LR, Colao A, Biller BM. High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clin Endocrinol (Oxf). 2014 Feb; 80(2):261-9. PMID: 23746264.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  50. Yuen KC, Biller BM, Katznelson L, Rhoads SA, Gurel MH, Chu O, Corazzini V, Spiller K, Gordon MB, Salvatori R, Cook DM. Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults. Pituitary. 2013 Jun; 16(2):220-30. PMID: 22806554.
    Citations: 8     Fields:    Translation:Humans
  51. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr. 2013 Aug; 102(8):787-96. PMID: 23586744.
    Citations: 6     Fields:    Translation:Humans
  52. Feldt-Rasmussen U, Brabant G, Maiter D, Jonsson B, Toogood A, Koltowska-Haggstrom M, Rasmussen AK, Buchfelder M, Saller B, Biller BM. Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak. Eur J Endocrinol. 2013 May; 168(5):733-43. PMID: 23416951.
    Citations: 2     Fields:    Translation:Humans
  53. Yuen KC, Conway GS, Popovic V, Merriam GR, Bailey T, Hamrahian AH, Biller BM, Kipnes M, Moore JA, Humphriss E, Bright GM, Cleland JL. A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults. J Clin Endocrinol Metab. 2013 Jun; 98(6):2595-603. PMID: 23585663.
    Citations: 9     Fields:    Translation:Humans
  54. Tritos NA, Hamrahian AH, King D, Greenspan SL, Cook DM, Jönsson PJ, Koltowska-Häggstrom M, Biller BM. Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency - a KIMS database analysis. Clin Endocrinol (Oxf). 2013 Aug; 79(2):178-84. PMID: 23278636.
    Citations:    Fields:    Translation:Humans
  55. Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller BM, Cook D, Yuen KC, Bonert V, Dobs A, Molitch ME, Merriam GR. Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2013 Jun; 98(6):2422-9. PMID: 23559086.
    Citations: 10     Fields:    Translation:Humans
  56. Fleseriu M, Molitch ME, Gross C, Schteingart DE, Vaughan TB, Biller BM. A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone. Endocr Pract. 2013 Mar-Apr; 19(2):313-26. PMID: 23337135.
    Citations: 15     Fields:    Translation:Humans
  57. Lin E, Wexler TL, Nachtigall L, Tritos N, Swearingen B, Hemphill L, Loeffler J, Biller BM, Klibanski A, Miller KK. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol (Oxf). 2012 Sep; 77(3):430-8. PMID: 22315983.
    Citations: 9     Fields:    Translation:Humans
  58. Sheth SA, Mian MK, Neal J, Tritos NA, Nachtigall L, Klibanski A, Biller BM, Swearingen B. Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. Neurosurgery. 2012 Jul; 71(1):14-22. PMID: 22353796.
    Citations: 3     Fields:    Translation:Humans
  59. Tritos NA, Hamrahian AH, King D, Greenspan SL, Cook DM, Jönsson PJ, Wajnrajch MP, Koltowska-Häggstrom M, Biller BM. A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis. Eur J Endocrinol. 2012 Sep; 167(3):343-51. PMID: 22711759.
    Citations: 6     Fields:    Translation:Humans
  60. Toogood A, Brabant G, Maiter D, Jonsson B, Feldt-Rasmussen U, Koltowska-Haggstrom M, Rasmussen AK, Buchfelder M, Saller B, Biller BM. Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation tests. Endocr Pract. 2012 May-Jun; 18(3):325-34. PMID: 22068248.
    Citations: 5     Fields:    Translation:Humans
  61. Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. J Clin Endocrinol Metab. 2012 Jun; 97(6):2039-49. PMID: 22466348.
    Citations: 81     Fields:    Translation:HumansCTClinical Trials
  62. Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM. A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med. 2012 Mar 08; 366(10):914-24. PMID: 22397653.
    Citations: 113     Fields:    Translation:HumansCTClinical Trials
  63. Valassi E, Brick DJ, Johnson JC, Biller BM, Klibanski A, Miller KK. Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders. Endocr Pract. 2012 Mar-Apr; 18(2):209-18. PMID: 22440981.
    Citations: 5     Fields:    Translation:Humans
  64. van der Lely AJ, Biller BM, Brue T, Buchfelder M, Ghigo E, Gomez R, Hey-Hadavi J, Lundgren F, Rajicic N, Strasburger CJ, Webb SM, Koltowska-Häggström M. Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. J Clin Endocrinol Metab. 2012 May; 97(5):1589-97. PMID: 22362824.
    Citations: 51     Fields:    Translation:HumansCTClinical Trials
  65. Tritos NA, Biller BM. Advances in medical therapies for Cushing's syndrome. Discov Med. 2012 Feb; 13(69):171-9. PMID: 22369976.
    Citations: 13     Fields:    Translation:HumansAnimals
  66. Ragnarsson O, Höybye C, Jönsson PJ, Feldt-Rasmussen U, Johannsson G, Biller BM, Koltowska-Häggström M. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood. Eur J Endocrinol. 2012 Apr; 166(4):593-600. PMID: 22258111.
    Citations: 3     Fields:    Translation:Humans
  67. Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennernäs H, Skrtic S. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012 Feb; 97(2):473-81. PMID: 22112807.
    Citations: 44     Fields:    Translation:Humans
  68. Valassi E, Biller BM, Klibanski A, Misra M. Adipokines and cardiovascular risk in Cushing's syndrome. Neuroendocrinology. 2012; 95(3):187-206. PMID: 22057123.
    Citations: 6     Fields:    Translation:Humans
  69. Swearingen B, Wu N, Chen SY, Pulgar S, Biller BM. Health care resource use and costs among patients with cushing disease. Endocr Pract. 2011 Sep-Oct; 17(5):681-90. PMID: 21454233.
    Citations: 8     Fields:    Translation:Humans
  70. Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ. Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency. J Clin Endocrinol Metab. 2011 Jun; 96(6):1718-26. PMID: 21411551.
    Citations: 10     Fields:    Translation:Humans
  71. Tritos NA, Greenspan SL, King D, Hamrahian A, Cook DM, Jönsson PJ, Wajnrajch MP, Koltowska-Häggstrom M, Biller BM. Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis. J Clin Endocrinol Metab. 2011 May; 96(5):1516-23. PMID: 21367928.
    Citations: 6     Fields:    Translation:Humans
  72. Tritos NA, Biller BM, Swearingen B. Management of Cushing disease. Nat Rev Endocrinol. 2011 May; 7(5):279-89. PMID: 21301487.
    Citations: 39     Fields:    Translation:Humans
  73. Valassi E, Biller BM, Klibanski A, Swearingen B. Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf). 2010 Dec; 73(6):798-807. PMID: 20874772.
    Citations: 11     Fields:    Translation:Humans
  74. Biller BM, Colao A, Petersenn S, Bonert VS, Boscaro M. Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas. BMC Endocr Disord. 2010 May 17; 10:10. PMID: 20478050.
    Citations: 10     Fields:    
  75. Petersenn S, Schopohl J, Barkan A, Mohideen P, Colao A, Abs R, Buchelt A, Ho YY, Hu K, Farrall AJ, Melmed S, Biller BM. Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial. J Clin Endocrinol Metab. 2010 Jun; 95(6):2781-9. PMID: 20410233.
    Citations: 47     Fields:    Translation:HumansCTClinical Trials
  76. Ross J, Czernichow P, Biller BM, Colao A, Reiter E, Kiess W. Growth hormone: health considerations beyond height gain. Pediatrics. 2010 Apr; 125(4):e906-18. PMID: 20308212.
    Citations: 11     Fields:    Translation:Humans
  77. Valassi E, Klibanski A, Biller BM. Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab. 2010 Mar; 95(3):1025-33. PMID: 20130078.
    Citations: 20     Fields:    Translation:Humans
  78. Höybye C, Ragnarsson O, Jönsson PJ, Koltowska-Häggström M, Trainer P, Feldt-Rasmussen U, Biller BM. Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease. Eur J Endocrinol. 2010 Apr; 162(4):677-84. PMID: 20089548.
    Citations: 7     Fields:    Translation:Humans
  79. Valassi E, Biller BM, Swearingen B, Pecori Giraldi F, Losa M, Mortini P, Hayden D, Cavagnini F, Klibanski A. Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab. 2010 Feb; 95(2):601-10. PMID: 20080848.
    Citations: 20     Fields:    Translation:Humans
  80. Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, Hemphill L, Nachtigall L, Loeffler J, Swearingen B, Biller BM, Klibanski A. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab. 2010 Feb; 95(2):567-77. PMID: 20061426.
    Citations: 14     Fields:    Translation:Humans
  81. Ghigo E, Biller BM, Colao A, Kourides IA, Rajicic N, Hutson RK, De Marinis L, Klibanski A. Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy. J Endocrinol Invest. 2009 Dec; 32(11):924-33. PMID: 20009494.
    Citations: 12     Fields:    Translation:Humans
  82. Biller BM, Sheppard M. The Network for the Enhancement of Endocrinology and Oncology Knowledge: a case-based consideration of current practice in Cushing's disease and acromegaly. Best Pract Res Clin Endocrinol Metab. 2009 Dec; 23 Suppl 1:S1-4. PMID: 20129189.
    Citations: 2     Fields:    Translation:Humans
  83. Tritos NA, Biller BM. Growth hormone and bone. Curr Opin Endocrinol Diabetes Obes. 2009 Dec; 16(6):415-22. PMID: 19770650.
    Citations: 16     Fields:    Translation:HumansAnimals
  84. Valassi E, Swearingen B, Lee H, Nachtigall LB, Donoho DA, Klibanski A, Biller BM. Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. J Clin Endocrinol Metab. 2009 Dec; 94(12):4851-9. PMID: 19850679.
    Citations: 6     Fields:    Translation:Humans
  85. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations. Endocr Pract. 2009 Sep-Oct; 15(6):580-6. PMID: 19858064.
    Citations: 11     Fields:    Translation:Humans
  86. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update. Endocr Pract. 2009 Sep-Oct; 15 Suppl 2:1-29. PMID: 20228036.
    Citations: 22     Fields:    Translation:Humans
  87. Nieman L, Biller B, Findling J, Newell-Price J, Savage M, Stewart P, Montori VM. WITHDRAWN: The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. Eur J Endocrinol. 2009 Aug 18. PMID: 19690086.
    Citations:    Fields:    
  88. Yuen KC, Biller BM, Molitch ME, Cook DM. Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab. 2009 Aug; 94(8):2702-7. PMID: 19509104.
    Citations: 27     Fields:    Translation:Humans
  89. Nachtigall LB, Valassi E, Lo J, McCarty D, Passeri J, Biller BM, Miller KK, Utz A, Grinspoon S, Lawson EA, Klibanski A. Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study. Clin Endocrinol (Oxf). 2010 Jan; 72(1):53-8. PMID: 19508591.
    Citations: 11     Fields:    Translation:Humans
  90. Wexler T, Gunnell L, Omer Z, Kuhlthau K, Beauregard C, Graham G, Utz AL, Biller B, Nachtigall L, Loeffler J, Swearingen B, Klibanski A, Miller KK. Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J Clin Endocrinol Metab. 2009 Jul; 94(7):2471-7. PMID: 19366847.
    Citations: 18     Fields:    Translation:Humans
  91. Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab. 2009 Jan; 94(1):115-22. PMID: 18957506.
    Citations: 65     Fields:    Translation:HumansCTClinical Trials
  92. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008 Jul; 93(7):2454-62. PMID: 18413427.
    Citations: 148     Fields:    Translation:Humans
  93. Beauregard C, Utz AL, Schaub AE, Nachtigall L, Biller BM, Miller KK, Klibanski A. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2008 Jun; 93(6):2063-71. PMID: 18381581.
    Citations: 30     Fields:    Translation:Humans
  94. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008 May; 93(5):1526-40. PMID: 18334580.
    Citations: 273     Fields:    Translation:Humans
  95. Aghi MK, Petit J, Chapman P, Loeffler J, Klibanski A, Biller BM, Swearingen B. Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery. Clin Neurosurg. 2008; 55:141-4. PMID: 19248680.
    Citations: 5     Fields:    Translation:Humans
  96. Biller BM. Concepts in the diagnosis of adult growth hormone deficiency. Horm Res. 2007; 68 Suppl 5:59-65. PMID: 18174710.
    Citations: 5     Fields:    Translation:Humans
  97. Petit JH, Biller BM, Yock TI, Swearingen B, Coen JJ, Chapman P, Ancukiewicz M, Bussiere M, Klibanski A, Loeffler JS. Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab. 2008 Feb; 93(2):393-9. PMID: 18029460.
    Citations: 19     Fields:    Translation:Humans
  98. Utz A, Biller BM. The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing's syndrome. Arq Bras Endocrinol Metabol. 2007 Nov; 51(8):1329-38. PMID: 18209871.
    Citations: 10     Fields:    Translation:Humans
  99. Petit JH, Biller BM, Coen JJ, Swearingen B, Ancukiewicz M, Bussiere M, Chapman P, Klibanski A, Loeffler JS. Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract. 2007 Nov-Dec; 13(7):726-34. PMID: 18194929.
    Citations: 15     Fields:    Translation:Humans
  100. Brabant G, Krogh Rasmussen A, Biller BM, Buchfelder M, Feldt-Rasmussen U, Forssmann K, Jonsson B, Koltowska-Haggstrom M, Maiter D, Saller B, Toogood A. Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency. J Clin Endocrinol Metab. 2007 Jul; 92(7):2604-9. PMID: 17488801.
    Citations: 5     Fields:    Translation:Humans
  101. Snyder PJ, Biller BM, Zagar A, Jackson I, Arafah BM, Nippoldt TB, Cook DM, Mooradian AD, Kwan A, Scism-Bacon J, Chipman JJ, Hartman ML. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency. J Bone Miner Res. 2007 May; 22(5):762-70. PMID: 17280527.
    Citations: 10     Fields:    Translation:Humans
  102. Miller KK, Biller BM, Schaub A, Pulaski-Liebert K, Bradwin G, Rifai N, Klibanski A. Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism. J Clin Endocrinol Metab. 2007 Jul; 92(7):2474-9. PMID: 17426086.
    Citations: 9     Fields:    Translation:Humans
  103. Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2006 May; 91(5):1683-90. PMID: 16478814.
    Citations: 30     Fields:    Translation:Humans
  104. Hoffman AR, Biller BM, Cook D, Baptista J, Silverman BL, Dao L, Attie KM, Fielder P, Maneatis T, Lippe B. Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab. 2005 Dec; 90(12):6431-40. PMID: 16159930.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  105. Utz AL, Swearingen B, Biller BM. Pituitary surgery and postoperative management in Cushing's disease. Endocrinol Metab Clin North Am. 2005 Jun; 34(2):459-78, xi. PMID: 15850853.
    Citations: 10     Fields:    Translation:Humans
  106. Miller KK, Biller BM, Lipman JG, Bradwin G, Rifai N, Klibanski A. Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab. 2005 Feb; 90(2):768-74. PMID: 15572428.
    Citations: 30     Fields:    Translation:Humans
  107. Owens G, Balfour D, Biller BM, Cohen J, Jacobs M, Lease M, Ratnesar R, Schaecher KL, Wilcox DE. Clinical presentation and diagnosis: growth hormone deficiency in adults. Am J Manag Care. 2004 Oct; 10(13 Suppl):S424-30. PMID: 15622874.
    Citations:    Fields:    Translation:Humans
  108. Swearingen B, Katznelson L, Miller K, Grinspoon S, Waltman A, Dorer DJ, Klibanski A, Biller BM. Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab. 2004 Aug; 89(8):3752-63. PMID: 15292301.
    Citations: 29     Fields:    Translation:Humans
  109. Hoffman AR, Kuntze JE, Baptista J, Baum HB, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schlechte J, Sharma M, Thorner MO, Vance ML. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004 May; 89(5):2048-56. PMID: 15126520.
    Citations: 31     Fields:    Translation:HumansCTClinical Trials
  110. Biller BMK. Growth hormone deficiency in adults. AACE Self-Assessment Profile in Endocrinology (ASAP), Dr. Pasquale Palumbo (ed), American Association of Clinical Endocrinologists. 2004.
  111. Garcia C, Biller BM, Klibanski A. The role of the clinical laboratory in the diagnosis of Cushing syndrome. Am J Clin Pathol. 2003 Dec; 120 Suppl:S38-45. PMID: 15298142.
    Citations: 1     Fields:    Translation:Humans
  112. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003 Mar 04; 138(5):424-9. PMID: 12614096.
    Citations: 146     Fields:    Translation:Humans
  113. Harris PE, Bouloux P-M, Biller BMK, editors. Endocrinology in Clinical Practice. 2003.
  114. Garcia C, Biller BMK, Klibanski A. The role of the clinical laboratory in the diagnosis of Cushing's syndrome. Am J Clin Path. 2003; 120(Suppl 1):S38-45.
  115. Cook DM, Biller BM, Vance ML, Hoffman AR, Phillips LS, Ford KM, Benziger DP, Illeperuma A, Blethen SL, Attie KM, Dao LN, Reimann JD, Fielder PJ. The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults. J Clin Endocrinol Metab. 2002 Oct; 87(10):4508-14. PMID: 12364427.
    Citations: 10     Fields:    Translation:Humans
  116. Miller KK, Biller BM, Hier J, Arena E, Klibanski A. Androgens and bone density in women with hypopituitarism. J Clin Endocrinol Metab. 2002 Jun; 87(6):2770-6. PMID: 12050248.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  117. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002 May; 87(5):2067-79. PMID: 11994342.
    Citations: 82     Fields:    Translation:HumansCTClinical Trials
  118. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab. 2002 Feb; 87(2):477-85. PMID: 11836272.
    Citations: 63     Fields:    Translation:Humans
  119. Anderson MS, Brogi E, Biller BM. Occult Leydig cell tumor in a patient with gynecomastia. Endocr Pract. 2001 Jul-Aug; 7(4):267-71. PMID: 11497478.
    Citations:    Fields:    Translation:Humans
  120. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab. 2001 Apr; 86(4):1518-24. PMID: 11297577.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  121. Biller, BMK. Growth hormone deficiency in adults. AACE Self-Assessment Profile in Endocrinology (ASAP), Dr. Pasquale Palumbo (ed), American Association of Clinical Endocrinologists. 2001.
  122. Biller BM, Vance ML, Kleinberg DL, Cook DM, Gordon T. Clinical and reimbursement issues in growth hormone use in adults. Am J Manag Care. 2000 Sep; 6(15 Suppl):S817-27. PMID: 11184423.
    Citations:    Fields:    Translation:Humans
  123. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med. 2000 Jul 18; 133(2):111-22. PMID: 10896637.
    Citations: 42     Fields:    Translation:HumansCTClinical Trials
  124. Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab. 2000 Mar; 85(3):970-6. PMID: 10720025.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  125. Biller BMK. Disorders of the pituitary gland and disorders of the adrenal gland in Medical Knowledge Self Assessment Program (MKSAP) 12. Charles Halen and William Kettyle (eds), American College of Physicians - American Society of Internal Medicine. 2000.
  126. Biller BM. Diagnostic evaluation of hyperprolactinemia. J Reprod Med. 1999 Dec; 44(12 Suppl):1095-9. PMID: 10649817.
    Citations: 2     Fields:    Translation:Humans
  127. Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, Sanfilippo J, Webster J, Zacur H. Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med. 1999 Dec; 44(12 Suppl):1075-84. PMID: 10649814.
    Citations: 16     Fields:    Translation:Humans
  128. Swearingen B, Biller BM, Barker FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med. 1999 May 18; 130(10):821-4. PMID: 10366371.
    Citations: 32     Fields:    Translation:Humans
  129. Biller BM. Hyperprolactinemia. Int J Fertil Womens Med. 1999 Mar-Apr; 44(2):74-7. PMID: 10338264.
    Citations: 3     Fields:    Translation:Humans
  130. Biller BMK. Cushing's syndrome. Atlas of Clinical Endocrinology. 1999; 4:157-71.
  131. Warren MP, Biller BM, Shangold MM. A new clinical option for hormone replacement therapy in women with secondary amenorrhea: effects of cyclic administration of progesterone from the sustained-release vaginal gel Crinone (4% and 8%) on endometrial morphologic features and withdrawal bleeding. Am J Obstet Gynecol. 1999 Jan; 180(1 Pt 1):42-8. PMID: 9914576.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  132. Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab. 1998 Oct; 83(10):3419-26. PMID: 9768641.
    Citations: 120     Fields:    Translation:Humans
  133. Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA, Cannistraro KE, Klibanski A. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab. 1998 Sep; 83(9):3184-9. PMID: 9745423.
    Citations: 25     Fields:    Translation:HumansCTClinical Trials
  134. Biller BMK. Efficacy of growth hormone replacement therapy: body composition and bone density. The Endocrinologist. 1998; 8:15S - 21S.
  135. Meier CA, Biller BM. Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am. 1997 Dec; 26(4):741-62. PMID: 9429858.
    Citations: 14     Fields:    Translation:Humans
  136. Biller BM, Swearingen B, Zervas NT, Klibanski A. A decade of the Massachusetts General Hospital Neuroendocrine Clinical Center. J Clin Endocrinol Metab. 1997 Jun; 82(6):1668-74. PMID: 9177360.
    Citations: 3     Fields:    Translation:Humans
  137. Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM, Klibanski A. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab. 1997 May; 82(5):1332-7. PMID: 9141512.
    Citations: 33     Fields:    Translation:Humans
  138. Biller BMK. Treatment of hyperprolactinemia with dopamine agonist cabergoline: clinical experience in the United States. The Endocrinologist (suppl). 1997; 7:405-8.
  139. Biller BMK, Daniels GH. . Neuroendocrine regulation and pituitary disease. Isselbacher KJ, Braunwald E, Wilson JD et al (eds). Harrison's Principles of Internal Medicine. 1997.
  140. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med. 1996 Dec 01; 125(11):883-90. PMID: 8967668.
    Citations: 40     Fields:    Translation:HumansCTClinical Trials
  141. Biller BM. Medical therapy for prolactinomas and somatotroph adenomas. Endocr Pract. 1996 Sep-Oct; 2(5):333-7. PMID: 15251513.
    Citations:    Fields:    
  142. Biller BM, Molitch ME, Vance ML, Cannistraro KB, Davis KR, Simons JA, Schoenfelder JR, Klibanski A. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab. 1996 Jun; 81(6):2338-43. PMID: 8964874.
    Citations: 36     Fields:    Translation:Humans
  143. Baum HB, Biller BM, Katznelson L, Oppenheim DS, Clemmons DR, Cannistraro KB, Schoenfeld DA, Best SA, Klibanski A. Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study. J Clin Endocrinol Metab. 1996 Jan; 81(1):84-92. PMID: 8550799.
    Citations: 10     Fields:    Translation:Humans
  144. Biller BMK. Medical therapy of prolactinomas and somatotroph adenomas. Endocrine Practice. 1996; 2:333-7.
  145. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995 Mar; 80(3):898-904. PMID: 7883849.
    Citations: 73     Fields:    Translation:HumansCTClinical Trials
  146. Zervas N, Biller BMK. Endocrine diagnosis in neurosurgery. Wilkins RH, Rengachary Ss (eds). 1995.
  147. Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab. 1994 Oct; 79(4):923-31. PMID: 7962298.
    Citations: 67     Fields:    Translation:Humans
  148. Biller BM. Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic. Endocrinol Metab Clin North Am. 1994 Sep; 23(3):547-54. PMID: 7805653.
    Citations: 3     Fields:    Translation:Humans
  149. Hsu DW, Hakim F, Biller BM, de la Monte S, Zervas NT, Klibanski A, Hedley-Whyte ET. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg. 1993 May; 78(5):753-61. PMID: 8096873.
    Citations: 39     Fields:    Translation:Humans
  150. Biller BM, Alexander JM, Zervas NT, Hedley-Whyte ET, Arnold A, Klibanski A. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab. 1992 Nov; 75(5):1303-9. PMID: 1358909.
    Citations: 14     Fields:    Translation:HumansCells
  151. Biller BM, Baum HB, Rosenthal DI, Saxe VC, Charpie PM, Klibanski A. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab. 1992 Sep; 75(3):692-7. PMID: 1517356.
    Citations: 15     Fields:    Translation:Humans
  152. Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med. 1992 Feb 27; 326(9):600-4. PMID: 1734250.
    Citations: 46     Fields:    Translation:Humans
  153. Biller BM, Coughlin JF, Saxe V, Schoenfeld D, Spratt DI, Klibanski A. Osteopenia in women with hypothalamic amenorrhea: a prospective study. Obstet Gynecol. 1991 Dec; 78(6):996-1001. PMID: 1945230.
    Citations: 6     Fields:    Translation:Humans
  154. Biller BMK. Amenorrhea and osteoporosis. The Endocrinologist. 1991; 1(5):294-300.
  155. Alexander JM, Biller BM, Bikkal H, Zervas NT, Arnold A, Klibanski A. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest. 1990 Jul; 86(1):336-40. PMID: 1973174.
    Citations: 61     Fields:    Translation:HumansCells
  156. Vance ML, Lipper M, Klibanski A, Biller BM, Samaan NA, Molitch ME. Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist CV 205-502. Ann Intern Med. 1990 May 01; 112(9):668-73. PMID: 1970714.
    Citations: 13     Fields:    Translation:Humans
  157. Biller BM, Federoff HJ, Koenig JI, Klibanski A. Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 1990 Feb; 70(2):311-7. PMID: 2153693.
    Citations: 23     Fields:    Translation:Humans
  158. Rosenthal DI, Mayo-Smith W, Hayes CW, Khurana JS, Biller BM, Neer RM, Klibanski A. Age and bone mass in premenopausal women. J Bone Miner Res. 1989 Aug; 4(4):533-8. PMID: 2816502.
    Citations: 32     Fields:    Translation:Humans
  159. Biller BM, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab. 1989 Mar; 68(3):548-54. PMID: 2493036.
    Citations: 66     Fields:    Translation:Humans
  160. Mayo-Smith W, Hayes CW, Biller BM, Klibanski A, Rosenthal H, Rosenthal DI. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology. 1989 Feb; 170(2):515-8. PMID: 2911678.
    Citations: 29     Fields:    Translation:Humans
  161. Klibanski A, Jameson JL, Biller BM, Crowley WF, Zervas NT, Rivier J, Vale WW, Bikkal H. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. J Clin Endocrinol Metab. 1989 Jan; 68(1):81-6. PMID: 2535852.
    Citations: 7     Fields:    Translation:Humans
  162. Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab. 1988 Jul; 67(1):124-30. PMID: 3379129.
    Citations: 23     Fields:    Translation:Humans
  163. Biller BMK, Klibanski A, Koenig J, Martin JB. Diagnostic dilemmas in management of hypothalamic-pitutiary-adrenal disorders. Ann NY Acad Sci. 1988; 512:338-50.
  164. Biller B, Klibanski A, Koenig J, Martin JB. Diagnostic dilemmas in the management of hypothalamic-pituitary-adrenal disorders. Ann N Y Acad Sci. 1987; 512:338-50. PMID: 3442374.
    Citations:    Fields:    Translation:Humans
  165. Spiler IJ, Kapcala LP, Graze K, Gagel RF, Feldman ZT, Biller B, Tashjian AH, Reichlin S. Effects of L-dopa and bromocriptine on calcitonin secretion in medullary thyroid carcinoma. J Clin Endocrinol Metab. 1980 Oct; 51(4):806-9. PMID: 7419666.
    Citations:    Fields:    Translation:Humans
  166. Dole VP, Crowther A, Johnson J, Monsalvatge M, Biller B, Nelson SS. Detection of narcotic, sedative, and amphetamine drugs in urine. Use of ion-exchange paper extraction. N Y State J Med. 1972 Feb 15; 72(4):471-6. PMID: 4501383.
    Citations:    Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Biller's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (436)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.